| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
|
Lancet
|
2008
|
19.65
|
|
2
|
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
|
J Natl Cancer Inst
|
2003
|
2.81
|
|
3
|
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.
|
Nat Med
|
2011
|
2.71
|
|
4
|
Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand.
|
J Acquir Immune Defic Syndr
|
2002
|
2.48
|
|
5
|
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.
|
Contemp Clin Trials
|
2008
|
2.35
|
|
6
|
Efficacy of the female condom as a barrier to semen during intercourse.
|
Am J Epidemiol
|
2003
|
2.20
|
|
7
|
Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom.
|
Am J Epidemiol
|
2003
|
1.92
|
|
8
|
The acceptability of the female and male condom: a randomized crossover trial.
|
Perspect Sex Reprod Health
|
2004
|
1.90
|
|
9
|
Maternal mortality among Afghan refugees in Pakistan, 1999-2000.
|
Lancet
|
2002
|
1.74
|
|
10
|
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.
|
J Clin Invest
|
2011
|
1.73
|
|
11
|
The use of nonhuman primate models in HIV vaccine development.
|
PLoS Med
|
2008
|
1.73
|
|
12
|
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
|
J Infect Dis
|
2003
|
1.71
|
|
13
|
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.
|
Curr Opin HIV AIDS
|
2010
|
1.63
|
|
14
|
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
|
J Infect Dis
|
2003
|
1.57
|
|
15
|
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.
|
Obstet Gynecol
|
2009
|
1.56
|
|
16
|
Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner.
|
Am J Obstet Gynecol
|
2013
|
1.45
|
|
17
|
Seroprevalence of human herpesvirus 8 infection in Northern Thailand.
|
Clin Infect Dis
|
2004
|
1.45
|
|
18
|
Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi.
|
Contemp Clin Trials
|
2006
|
1.45
|
|
19
|
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV.
|
J Low Genit Tract Dis
|
2007
|
1.37
|
|
20
|
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.
|
Obstet Gynecol
|
2010
|
1.31
|
|
21
|
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus.
|
Int J Cancer
|
2006
|
1.28
|
|
22
|
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
|
J Infect Dis
|
2003
|
1.28
|
|
23
|
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.
|
J Acquir Immune Defic Syndr
|
2008
|
1.26
|
|
24
|
Breast milk and HIV-1: vector of transmission or vehicle of protection?
|
Lancet Infect Dis
|
2003
|
1.20
|
|
25
|
Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial.
|
Am J Epidemiol
|
2007
|
1.20
|
|
26
|
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.
|
Am J Epidemiol
|
2006
|
1.20
|
|
27
|
Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007.
|
AIDS
|
2007
|
1.19
|
|
28
|
Self-reported mechanical problems during condom use and semen exposure. Comparison of two randomized trials in the United States of America and Brazil.
|
Sex Transm Dis
|
2007
|
1.13
|
|
29
|
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection.
|
Am J Obstet Gynecol
|
2002
|
1.12
|
|
30
|
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.
|
PLoS One
|
2010
|
1.09
|
|
31
|
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.
|
AIDS Educ Prev
|
2009
|
1.07
|
|
32
|
Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
|
Obstet Gynecol
|
2006
|
1.06
|
|
33
|
Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort.
|
J Acquir Immune Defic Syndr
|
2005
|
1.06
|
|
34
|
Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.
|
J Infect Dis
|
2003
|
1.05
|
|
35
|
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.
|
PLoS Pathog
|
2011
|
1.00
|
|
36
|
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
|
Clin Infect Dis
|
2002
|
0.97
|
|
37
|
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women.
|
J Acquir Immune Defic Syndr
|
2007
|
0.97
|
|
38
|
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study.
|
AIDS
|
2011
|
0.94
|
|
39
|
The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.
|
Sex Transm Dis
|
2002
|
0.93
|
|
40
|
Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection.
|
Pediatrics
|
2006
|
0.93
|
|
41
|
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.
|
AIDS Res Hum Retroviruses
|
2010
|
0.93
|
|
42
|
Accuracy of Papanicolaou test among HIV-infected women.
|
Clin Infect Dis
|
2006
|
0.92
|
|
43
|
Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection.
|
Infect Dis Obstet Gynecol
|
2005
|
0.92
|
|
44
|
Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.
|
J Acquir Immune Defic Syndr
|
2006
|
0.92
|
|
45
|
Reproductive options for HIV-serodiscordant couples.
|
AIDS Rev
|
2006
|
0.90
|
|
46
|
Comparing Measures of Late HIV Diagnosis in Washington State.
|
AIDS Res Treat
|
2011
|
0.89
|
|
47
|
Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
|
J Infect Dis
|
2007
|
0.89
|
|
48
|
Safe conception for HIV discordant couples through sperm-washing: experience and perceptions of patients in Milan, Italy.
|
Reprod Health Matters
|
2008
|
0.88
|
|
49
|
Predictors of low CD4 count in resource-limited settings: based on an antiretroviral-naive heterosexual thai population.
|
J Acquir Immune Defic Syndr
|
2005
|
0.87
|
|
50
|
Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection.
|
Am J Clin Nutr
|
2007
|
0.85
|
|
51
|
Implications of blood contamination for assessment of local cellular immunity in the endocervix.
|
AIDS Res Hum Retroviruses
|
2004
|
0.84
|
|
52
|
Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
|
AIDS Res Hum Retroviruses
|
2002
|
0.82
|
|
53
|
The potential role of biomarkers in HIV preventive vaccine trials.
|
J Acquir Immune Defic Syndr
|
2009
|
0.81
|
|
54
|
High prevalence of self-reported forced sexual intercourse among internally displaced women in Azerbaijan.
|
Am J Public Health
|
2003
|
0.80
|
|
55
|
Frequencies of IL10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais.
|
Asian Pac J Allergy Immunol
|
2011
|
0.80
|
|
56
|
Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop.
|
J Acquir Immune Defic Syndr
|
2007
|
0.79
|
|
57
|
Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy.
|
J Acquir Immune Defic Syndr
|
2004
|
0.79
|
|
58
|
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition.
|
AIDS
|
2016
|
0.78
|
|
59
|
Do women with HIV infection have different indications for hysterectomy?
|
J Acquir Immune Defic Syndr
|
2005
|
0.78
|
|
60
|
Reply to Richie and Villasante.
|
J Infect Dis
|
2012
|
0.77
|
|
61
|
HIV-discordant couples and parenthood: how are we dealing with the risk of transmission?
|
AIDS
|
2006
|
0.77
|
|
62
|
HIV vaccine efficacy trials: towards the future of HIV prevention.
|
Infect Dis Clin North Am
|
2007
|
0.76
|
|
63
|
Lymphocyte homeostasis in HIV-infected northern Thais.
|
AIDS Res Hum Retroviruses
|
2004
|
0.76
|
|
64
|
HIV treatment as prevention: [corrected] next steps.
|
Curr Opin HIV AIDS
|
2012
|
0.75
|
|
65
|
Prevention of perinatal HIV transmission: a review of novel strategies.
|
Expert Opin Investig Drugs
|
2003
|
0.75
|